Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease

被引:77
|
作者
Shukla, Pradeep K. [1 ]
Delotterie, David F. [2 ]
Xiao, Jianfeng [2 ]
Pierre, Joseph F. [3 ]
Rao, RadhaKrishna [1 ]
McDonald, Michael P. [2 ,4 ,5 ]
Khan, Mohammad Moshahid [2 ,5 ,6 ,7 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Coll Med, Memphis, TN 38163 USA
[2] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Neurol, Memphis, TN 38163 USA
[3] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pediat, Memphis, TN 38163 USA
[4] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Anat & Neurobiol, Memphis, TN 38163 USA
[5] Univ Tennessee, Hlth Sci Ctr, Neurosci Inst, Memphis, TN 38163 USA
[6] Univ Tennessee, Hlth Sci Ctr, Ctr Muscle Metab & Neuropathol, Div Rehabil Sci, Memphis, TN 38163 USA
[7] Univ Tennessee, Hlth Sci Ctr, Dept Phys Therapy, Coll Hlth Profess, Memphis, TN 38163 USA
关键词
alzheimer’ s disease; gut microbiota; NLRP3; inflammasome; amyloid-beta; neuroinflammation;
D O I
10.3390/cells10040779
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population. Despite decades of scientific research, the underlying etiological triggers are unknown. Recent studies suggested that gut microbiota can influence AD progression; however, potential mechanisms linking the gut microbiota with AD pathogenesis remain obscure. In the present study, we provided a potential mechanistic link between dysbiotic gut microbiota and neuroinflammation associated with AD progression. Using a mouse model of AD, we discovered that unfavorable gut microbiota are correlated with abnormally elevated expression of gut NLRP3 and lead to peripheral inflammasome activation, which in turn exacerbates AD-associated neuroinflammation. To this end, we observe significantly altered gut microbiota compositions in young and old 5xFAD mice compared to age-matched non-transgenic mice. Moreover, 5xFAD mice demonstrated compromised gut barrier function as evident from the loss of tight junction and adherens junction proteins compared to non-transgenic mice. Concurrently, we observed increased expression of NLRP3 inflammasome and IL-1 beta production in the 5xFAD gut. Consistent with our hypothesis, increased gut-microbial-inflammasome activation is positively correlated with enhanced astrogliosis and microglial activation, along with higher expression of NLRP3 inflammasome and IL-1 beta production in the brains of 5xFAD mice. These data indicate that the elevated expression of gut-microbial-inflammasome components may be an important trigger for subsequent downstream activation of inflammatory and potentially cytotoxic mediators, and gastrointestinal NLRP3 may promote NLRP3 inflammasome-mediated neuroinflammation. Thus, modulation of the gut microbiota may be a potential strategy for the treatment of AD-related neurological disorders in genetically susceptible hosts.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
    Kesika, Periyanaina
    Suganthy, Natarajan
    Sivamaruthi, Bhagavathi Sundaram
    Chaiyasut, Chaiyavat
    LIFE SCIENCES, 2021, 264
  • [2] Alzheimer's disease and gut-brain axis: Drosophila melanogaster as a model
    Alves, Samuel de Mattos
    Lisboa-Filho, Paulo Noronha
    Zilli Vieira, Carolina Leticia
    Piacenti-Silva, Marina
    FRONTIERS IN NEUROSCIENCE, 2025, 19
  • [3] A Metabologenomic approach reveals alterations in the gut microbiota of a mouse model of Alzheimer's disease
    Favero, Francesco
    Barberis, Elettra
    Gagliardi, Mara
    Espinoza, Stefano
    Contu, Liliana
    Gustincich, Stefano
    Boccafoschi, Francesca
    Borsotti, Chiara
    Lim, Dmitry
    Rubino, Vito
    Mignone, Flavio
    Pasolli, Edoardo
    Manfredi, Marcello
    Zucchelli, Silvia
    Cora, Davide
    Corazzari, Marco
    PLOS ONE, 2022, 17 (08):
  • [4] Brain-Gut-Microbiota Axis in Alzheimer's Disease
    Kowalski, Karol
    Mulak, Agata
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 25 (01) : 48 - 60
  • [5] Polyphenols in Alzheimer's Disease and in the Gut-Brain Axis
    Reddy, V. Prakash
    Aryal, Puspa
    Robinson, Sara
    Rafiu, Raheemat
    Obrenovich, Mark
    Perry, George
    MICROORGANISMS, 2020, 8 (02)
  • [6] Longitudinal and Multi-Kingdom Gut Microbiome Alterations in a Mouse Model of Alzheimer's Disease
    Zhang, Tao
    Zhao, Chunyan
    Li, Na
    He, Qiuwen
    Gao, Guangqi
    Sun, Zhihong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [7] Cadmium exposure modulates the gut-liver axis in an Alzheimer's disease mouse model
    Zhang, Angela
    Matsushita, Megumi
    Zhang, Liang
    Wang, Hao
    Shi, Xiaojian
    Gu, Haiwei
    Xia, Zhengui
    Cui, Julia Yue
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [8] Cadmium exposure modulates the gut-liver axis in an Alzheimer’s disease mouse model
    Angela Zhang
    Megumi Matsushita
    Liang Zhang
    Hao Wang
    Xiaojian Shi
    Haiwei Gu
    Zhengui Xia
    Julia Yue Cui
    Communications Biology, 4
  • [9] The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions
    Murray, Emily R.
    Kemp, Mylon
    Nguyen, Tanya T.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2022, 37 (03) : 595 - 607
  • [10] The role of kynurenine pathway metabolism mediated by exercise in the microbial-gut-brain axis in Alzheimer's disease
    Wang, Yiyang
    Wu, Weijia
    Zeng, Fanqi
    Meng, Xiangyuan
    Peng, Mei
    Wang, Juan
    Chen, Zeyu
    Liu, Wenfeng
    EXPERIMENTAL NEUROLOGY, 2025, 384